Literature DB >> 11551924

Differential regulation of phosphoinositide metabolism by alphaVbeta3 and alphaVbeta5 integrins upon smooth muscle cell migration.

F Paulhe1, C Racaud-Sultan, A Ragab, C Albiges-Rizo, H Chap, N Iberg, O Morand, B Perret.   

Abstract

Smooth muscle cell migration is a key step of atherosclerosis and angiogenesis. We demonstrate that alpha(V)beta(3) and alpha(V)beta(5) integrins synergistically regulate smooth muscle cell migration onto vitronectin. Using an original haptotactic cell migration assay, we measured a strong stimulation of phosphoinositide metabolism in migrating vascular smooth muscle cells. Phosphatidic acid production and phosphoinositide 3-kinase IA activation were triggered only upon alpha(V)beta(3) engagement. Blockade of alpha(V)beta(3) engagement or phospholipase C activity resulted in a strong inhibition of smooth muscle cell spreading on vitronectin. By contrast, blockade of alpha(V)beta(5) reinforced elongation and polarization of cell shape. Moreover, Pyk2-associated tyrosine kinase and phosphoinositide 4-kinase activities measured in Pyk2 immunoprecipitates were stimulated upon cell migration. Blockade of either alpha(V)beta(3) or alpha(V)beta(5) function, as well as inhibition of phospholipase C activity, decreased both Pyk2-associated activities. We demonstrated that the Pyk2-associated phosphoinositide 4-kinase corresponded to the beta isoform. Our data point to the metabolism of phosphoinositides as a regulatory pathway for the differential roles played by alpha(V)beta(3) and alpha(V)beta(5) upon cell migration and identify the Pyk2-associated phosphoinositide 4-kinase beta as a common target for both integrins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551924     DOI: 10.1074/jbc.M105459200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice.

Authors:  Seppo Ylä-Herttula; Juhani Knuuti; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

2.  Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies.

Authors:  Yrjö T Konttinen; Zygmunt Mackiewicz; Danute Povilenaite; Antti Sukura; Mika Hukkanen; Ismo Virtanen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

Review 3.  Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.

Authors:  Ephraim A Ansa-Addo; Jessica Thaxton; Feng Hong; Bill X Wu; Yongliang Zhang; Caroline W Fugle; Alessandra Metelli; Brian Riesenberg; Katelyn Williams; Daniel T Gewirth; Gabriela Chiosis; Bei Liu; Zihai Li
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

4.  Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.

Authors:  Stephan Niland; Johannes A Eble
Journal:  J Oncol       Date:  2011-09-18       Impact factor: 4.375

5.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

6.  High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in Watanabe rabbits.

Authors:  Julie Heroux; Ahmed M Gharib; Narasimhan S Danthi; Sylvain Cecchini; Jacques Ohayon; Roderic I Pettigrew
Journal:  Mol Imaging Biol       Date:  2010 Jan-Feb       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.